149 related articles for article (PubMed ID: 30350180)
21. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
22. The combination of 13N-ammonia and 18F-FDG PET/CT in the identification of metabolic phenotype of primary human brain tumors.
Yi C; Shi X; Yu D; Luo G; Zhang B; He Q; Zhang X
Nuklearmedizin; 2019 Jun; 58(3):272-278. PubMed ID: 30995685
[TBL] [Abstract][Full Text] [Related]
23. Oligodendroglial component complicates the prediction of tumour grading with metabolic imaging.
Manabe O; Hattori N; Yamaguchi S; Hirata K; Kobayashi K; Terasaka S; Kobayashi H; Motegi H; Shiga T; Magota K; Oyama-Manabe N; Nishijima K; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2015 May; 42(6):896-904. PubMed ID: 25647076
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic performance of apparent diffusion coefficient parameters for glioma grading.
Wang Q; Zhang J; Xu X; Chen X; Xu B
J Neurooncol; 2018 Aug; 139(1):61-68. PubMed ID: 29574566
[TBL] [Abstract][Full Text] [Related]
25. Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods?
Pöpperl G; Kreth FW; Herms J; Koch W; Mehrkens JH; Gildehaus FJ; Kretzschmar HA; Tonn JC; Tatsch K
J Nucl Med; 2006 Mar; 47(3):393-403. PubMed ID: 16513607
[TBL] [Abstract][Full Text] [Related]
26. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases.
Sparacia G; Gadde JA; Iaia A; Sparacia B; Midiri M
Neuroradiol J; 2016 Jun; 29(3):160-7. PubMed ID: 26988081
[TBL] [Abstract][Full Text] [Related]
28. Pattern of FDG and MET Distribution in High- and Low-Grade Gliomas on PET Images.
Takahashi M; Soma T; Mukasa A; Tanaka S; Yanagisawa S; Momose T
Clin Nucl Med; 2019 Apr; 44(4):265-271. PubMed ID: 30688731
[TBL] [Abstract][Full Text] [Related]
29. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy of MRI texture analysis for grading gliomas.
Ditmer A; Zhang B; Shujaat T; Pavlina A; Luibrand N; Gaskill-Shipley M; Vagal A
J Neurooncol; 2018 Dec; 140(3):583-589. PubMed ID: 30145731
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of malignancy in ring enhancing brain lesions on CT by thallium-201 SPECT.
Källén K; Heiling M; Andersson AM; Brun A; Holtås S; Ryding E; Rosén I
J Neurol Neurosurg Psychiatry; 1997 Nov; 63(5):569-74. PubMed ID: 9408094
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of ¹¹C-methionine positron emission tomography for treatment-decision making in cases of non-enhancing glioma-like brain lesions.
Watanabe A; Muragaki Y; Maruyama T; Shinoda J; Okada Y
J Neurooncol; 2016 Feb; 126(3):577-83. PubMed ID: 26612734
[TBL] [Abstract][Full Text] [Related]
34. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
Fueger BJ; Czernin J; Cloughesy T; Silverman DH; Geist CL; Walter MA; Schiepers C; Nghiemphu P; Lai A; Phelps ME; Chen W
J Nucl Med; 2010 Oct; 51(10):1532-8. PubMed ID: 20847166
[TBL] [Abstract][Full Text] [Related]
35. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
[TBL] [Abstract][Full Text] [Related]
36. [Dynamic11C-methionine PET/CT in differential diagnosis of brain gliomas].
Vikhrova NB; Kalaeva DB; Postnov AA; Khokhlova EV; Konakova TA; Batalov AI; Pogosbekyan EL; Pronin IN
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(3):5-13. PubMed ID: 34156203
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Value of O-(2-[18F]-Fluoroethyl)-L-Tyrosine-Positron Emission Tomography Imaging for Histopathologic Characteristics and Progression-Free Survival in Patients with Low-Grade Glioma.
Bette S; Gempt J; Delbridge C; Kirschke JS; Schlegel J; Foerster S; Huber T; Pyka T; Zimmer C; Meyer B; Ringel F
World Neurosurg; 2016 May; 89():230-9. PubMed ID: 26855307
[TBL] [Abstract][Full Text] [Related]
38.
Albano D; Giubbini R; Bertagna F
Jpn J Radiol; 2019 Dec; 37(12):799-807. PubMed ID: 31599383
[No Abstract] [Full Text] [Related]
39. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
40. 111In-labelled bleomycin complex for the differentiation of high- and low-grade gliomas.
Korppi-Tommola T; Huhmar H; Aronen HJ; Penttilä P; Hiltunen J; Savolainen S; Kallio ME; Liewendahl K
Nucl Med Commun; 1999 Feb; 20(2):145-52. PubMed ID: 10088163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]